NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
    • Research Themes Overview
    • Cancer
    • Cardiovascular Medicine
    • Digital Health from Hospital to Home
    • Gene and Cell Therapy
    • Genomic Medicine
    • Imaging
    • Inflammation across Tissues
    • Life-saving Vaccines
    • Metabolic Experimental Medicine
    • Modernising Medical Microbiology and Big Infection Diagnostics
    • Musculoskeletal
    • Preventive Neurology
    • Respiratory Medicine
    • Surgical Innovation, Technology and Evaluation
    • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Cardiovascular Medicine

You are here: Home > Research Themes Overview > Cardiovascular Medicine

Cardiovascular Medicine

Cardiovascular disease (CVD) accounts for a quarter of all deaths in the UK and is the largest cause of premature mortality in deprived areas. The NHS Long-Term Plan (2019) says that CVD is the “single biggest area where the NHS can save lives over the next 10 years”. Making the most of Oxford’s strengths in population and discovery science and advances made in previous BRCs, we will work with patients to tackle this problem.

Shutterstock.com

Our researchers are working to develop ways of intervening earlier in the care pathway to prevent future cardiovascular risk, for example in mothers, or trying reduce the risk of people with CVD going on to have heart attacks and strokes.

We have some powerful tools at our disposal: the Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), the world’s only centre that integrates an interventional suite with the first clinical photon-counting CT scanner and utilises artificial intelligence infrastructure and expertise; a number of Oxford-led national and international resources, such as the UK Obstetric Surveillance System (UKOSS) and the UK Biobank.

We also have a strong track record of collaborations with industry and spin-out companies in this area, as well as working with patient groups, who helped to set the priorities for this theme.

Our work encompasses three sub-themes:

Sub-theme 1: Identifying and validating new therapeutic targets

Leads: Professor Claudia Monaco, Professor Jemma Hopewell

We are aiming to identify new drug targets – and repurposing existing drugs – that work in different patient populations, using complementary approaches: the use of big patient datasets to analyse the genetic aspects; and single-cell biology techniques using human tissue. Read more

Sub-theme 2: Applying new technologies to improve personalised prevention and management of CVD

Lead: Professor Charalambos Antoniades

The overarching aim of this sub-theme is to use cutting-edge technology to develop highly accurate non-invasive methods of diagnosing CVD, where currently it has had to be achieved through invasive procedures.

This includes state-of-the-art imaging techniques, such as our new photon-counting CT scanner; developing new radiotranscriptomic platforms and artificial intelligence systems to identify cytokine-driven vascular inflammation from routine CT images; or better understanding the genetic factors that increase the risk of inherited heart conditions. Read more

Sub-theme 3. Addressing maternal cardiovascular risk

Leads: Professor Marian Knight, Professor Paul Leeson

We are bringing together our strengths in population health and discovery science to address the leading cause of death during and after pregnancy in the UK: acquired CVD. Drawing on our work across the theme, we are aiming to understand which mothers are at greatest risk of developing CVD in future, what interventions might reduce that risk, and which new therapies have the potential to translate into use in the NHS after clinical trials. Read more

Cardiovascular Medicine

  • Cardiovascular Medicine
  • Sub-theme 1: Identifying and validating new therapeutic targets
  • Sub-theme 2: Applying new technologies to improve personalised prevention and management of CVD
  • Sub-theme 3: Addressing maternal cardiovascular risk
  • NIHR–British Heart Foundation Cardiovascular Partnership
    • NIHR-BHF collaborative projects
    • NIHR-BHF highlights
    • NIHR-BHF news and events
  • OxVasc: Oxford Vascular Study
  • OxVALVE: Oxford Valve Study
  • Contacts
  • Videos
  • News

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre